Edition:
India

SMA Solar Technology AG (S92G.DE)

S92G.DE on Xetra

38.72EUR
21 Jun 2018
Change (% chg)

-- (--)
Prev Close
€38.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
96,292
52-wk High
€63.15
52-wk Low
€25.92

Latest Key Developments (Source: Significant Developments)

SMA Solar Technology Enters Into Purchase Agreement To Be Supplier For Sunrun
Tuesday, 23 Jan 2018 

Jan 23 (Reuters) - SMA SOLAR ::ENTERS INTO PURCHASE AGREEMENT TO BE SUPPLIER FOR SUNRUN.ENTERED INTO A PURCHASE AGREEMENT WITH SUNRUN, ONE OF TOP RESIDENTIAL SOLAR INSTALLERS.  Full Article

SMA Solar 2018 sales likely to be impacted by supply issues-CEO
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Sma Solar :Ceo says 2018 sales will likely be impacted by supply issues, currently looking to contract additional suppliers of key components.Ceo says supply problem is about insufficient availability of components.Ceo says business we have secured in utility segment in united states is quite promising.Cfo says could reach high end of our 2017 ebitda outlook.  Full Article

SMA Solar CEO says experiencing some delays in projects in U.S.
Thursday, 11 Aug 2016 

Sma Solar Technology Ag : Ceo says we experience some delays in projects in u.s. Market, but overall situation is intact . Ceo says sees strong interest from strategic investors in sma railway technology unit it is trying to sell Further company coverage: [S92G.DE] (Frankfurt newsroom) ((+49 69 7565 1270; Reuters Messaging: frankfurt.newsroom@thomsonreuters.net)).  Full Article

SMA Solar CEO says July earnings nearly matched all of Q2
Thursday, 11 Aug 2016 

SMA Solar Technology AG CEO tells Reuters : Earnings in July were nearly as good as whole Q2 . Aims to lower fixed costs by another 15 percent in coming months Further company coverage: [S92G.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

SMA Solar says upper end of forecast range is ambitious
Thursday, 11 Aug 2016 

SMA Solar : H1 sales rose 15.1 percent to 494.1 million eur . H1 profit 19.4 million eur versus -21.4 million eur loss year ago . Is anticipating a further intensification of price pressure in 2017 compared to current year . Announcing closure of production locations in Denver, USA, and Cape Town, South Africa .Upper end of forecast earnings range is ambitious given price developments in solar industry.  Full Article

Roche SMA drug shines in study as costly new therapies advance

ZURICH A drug being co-developed by Roche to treat spinal muscular atrophy (SMA) helped improve development scores in babies with the genetic disease, a study released on Monday showed, as the race heats up for therapies destined to be among the drug industry's most expensive.